Trans Genic Inc operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Trans Genic Inc with three other
companies in this sector in Japan:
Japan Tissue Engineering Company Limited
sales of 1.43 billion Japanese Yen [US$13.84 million]
of which 93%
was Regenerative Medicine Products Business),
SanBio Co Ltd
(1.17 billion Japanese Yen [US$11.36 million]
PhoenixBio Co Ltd
(1.22 billion Japanese Yen [US$11.77 million]
During the year ended March of 2016, sales at
Trans Genic Inc were ¥2.29 billion (US$22.15 million).
increase of 16.9%
versus 2015, when the company's sales were ¥1.96 billion.
This was the fifth consecutive year of sales increases at Trans Genic Inc
(and since 2011, sales have increased a total of 350%).